Rectal Adenocarcinoma — Trials

Rectal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

187 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 52
Recruiting: 28
Ph III recruiting: 3
Growth YoY: —
Industry share: 2%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03594630	Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer	recruiting	Early Phase 1	120	M.D. Anderson Cancer CenterOTHER	1	May 20, 2026	clinicaltrials
NCT05108428	Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma	active not recruiting	Early Phase 1	20	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Apr 1, 2026	clinicaltrials